The Ministry of Health and Avoidance has revealed the reduction of the costs of chosen medicines adhering to in partnership with the global pharmaceutical company Sanofi Aventis as part of the ministry's regular testimonials carried out together with international business to re-price medications to support patients and boost access to cost effective medicines.

H.E. Dr. Amin Hussein Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing and Vice Chairman of the Higher committee for Medicine Prices and Registration, said that the cost changes were done in according to Ministerial Decree No. (1400) of 2017 provided by H.E. Abdul Rahman Bin Mohammed Al Owais, Minister of Health and Prevention and in accordance with the Federal Legislation No. (1) of 1972 on the functions of ministries and the empowerment of ministers and Federal Law No. (4) of 1983 on the career of drug store and pharmaceutical establishments and mandate of the ministers cupboard No. (140) of 2013 on establishing the prices of medicines and calculating new currency exchange rate for international currency, along with the changes of the abovementioned legislations. The step develops part of the Ministry's commitment to supply top quality medicines priced inning accordance with regional requirements along with boost the medical care solutions in the UAE according to the smart management's vision and support for the health market to consistently guarantee the most effective results.

Reduction of the prices of 7 products

Inning Accordance With H.E. Al Amiri, products subject to price decrease reward numerous disorders including bacterial infections; joint discomfort, epileptic seizures, heart attack, prostate cancer cells, diabetes mellitus, and breast cancer have been reduced by up to 24 per cent. The Ministry said it has actually collaborated with Sanofi Pharma and local agents to ensure that the new expenses will certainly be implemented throughout the country. With the brand-new modification, the costs of 8,732 medications have been reduced given that the beginning of the Ministry's collection of price reduction campaigns on July 2, 2011.

Partnership with pharmaceutical companies has benefited patients with chronic diseases

H.E. said that the fruitful and positive participation among stakeholders from the general public and economic sectors has profited all individuals, particularly those with persistent conditions, heart health problem, and cancer, to name a few, that require lasting treatment.

The rate decreases, particularly, will especially profit individuals with persistent conditions or cancer who require long term therapy. Reducing the rates of high-grade medicines along with the arrangement of budget friendly pharmaceutical services is also the outcome of tactical partnership in between the Ministry of Health and Avoidance and global pharmaceutical companies running in the nation. It intends to urge the private sector to invest in the local health system and build new ties based on depend on, communication, transparency, and community assistance.

H.E. also said that encouraging global pharmaceutical companies to locally make their products will dramatically lower the rates of medicines. This will certainly not only offer individuals an accessibility to budget-friendly yet innovative medications but it will additionally profit local factories with modern technology transfer.

7 Cabinet initiatives launched in cooperation with pharmaceutical companies

H.E. Al Amiri praised the international pharmaceutical companies for their energetic participation in and quick action to the Ministry of Health and Prevention's efforts aimed at minimizing the costs of medications. Numerous global pharmaceutical companies have actually set their regional head office in the UAE and each of them presently utilizes 100 to 500 employees. Their logistic hubs are mainly located in airport terminals and cost-free areas in the UAE to sustain their procedures in the UAE and various other nations in the Middle East and North Africa. Bring in regional and global firms provides pride for the UAE as it shows their confidence in the country and its wise management.

The initial effort adjusted the prices of 565 innovative medicines on 1 July 2011, while the 2nd effort reduced the expenses of 115 common drugs on January First 2012. The 3rd effort reduced the rates of 6, 791 medicines on the very first of June 2013; 4th targeted 207 products on the first of January 2014; fifth minimized the rates of 280 medications on February Second 2015; the 6th and seventh lowered the prices of 142 products and 762 products on the 1st of January 1 and the 1st of September respectively.

Monitoring drug supply in UAE

H.E. assured that the Ministry will continually collaborate with business and distributors and check the medication supply in the country to ensure accessibility and prevent medicine shortage. The Ministry additionally monitors pharmaceutical companies to guarantee conformity with correct storage criteria and distribution process to stop any kind of damage and ensure optimum client treatment. The Ministry will publish on its site and local newspapers a checklist of medications with their new costs to stop any type of violations and to benefit all clients in the UAE.